Loading…
Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1- b]-1,3,4-thiadiazole derivatives
[Display omitted] A series of 2-sulfonamido/trifluoromethyl-6-(4′-substituted aryl/heteroaryl)imidazo[2,1- b]-1,3,4-thiadiazole derivatives ( II) have been synthesized by reaction of 2-amino-5-sulfonamido/trifluoromethyl-1,3,4-thiadiazoles and an appropriate α-haloaryl/heteroaryl ketones. Further 5-...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2004-11, Vol.12 (21), p.5651-5659 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
A series of 2-sulfonamido/trifluoromethyl-6-(4′-substituted aryl/heteroaryl)imidazo[2,1-
b]-1,3,4-thiadiazole derivatives (
II) have been synthesized by reaction of 2-amino-5-sulfonamido/trifluoromethyl-1,3,4-thiadiazoles and an appropriate α-haloaryl/heteroaryl ketones. Further 5-bromo (
III), 5-thiocyanato (
IV), 5-gaunylhydrazone (
V) derivatives were synthesized in order to study the effect of these substituents on biological activity. Structures of these compounds were established by IR,
1H NMR,
13C NMR, Mass and HRMS. The selected compounds were evaluated for their preliminary in vitro anti-tuberculosis activity against
Mycobacterium tuberculosis H37Rv strain using radiometric BACTEC and broth dilution assay methods. The results show that compounds
5,
7,
8,
10 and
12 exhibited moderate to good anti-tubercular activity with percentage inhibition of 29, 43, 58, 31 and 41, respectively, at a MIC of >6.25
μg/mL. Compound
18 showed a MIC of 20
μg/mL. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2004.07.060 |